2025 European Pharma & Biotech Spending Outlook
The European pharma and biotech industry is navigating a dynamic landscape, driven by rising healthcare demand, evolving trade policies, and groundbreaking advancements like AI and mRNA technology.
In this episode of Navigating the Currents of Change, host Shaheen Chohan, VP of Global Analytics at Industrial Info Resources, joins Joe Apostol, European Regional Manager for Pharma & Biotech, to explore the sector's future. From the impact of tariffs and sustainability initiatives to the growth of CMO/CDMO markets, this conversation connects the dots on the trends shaping the industry.
Key insights covered:
In this episode of Navigating the Currents of Change, host Shaheen Chohan, VP of Global Analytics at Industrial Info Resources, joins Joe Apostol, European Regional Manager for Pharma & Biotech, to explore the sector's future. From the impact of tariffs and sustainability initiatives to the growth of CMO/CDMO markets, this conversation connects the dots on the trends shaping the industry.
Key insights covered:
- The impact of import tariffs on capital expenditure and manufacturing decisions.
- The significant growth of the CMO/CDMO market and the rise of oncology and ADC investments.
- Emerging trends in mRNA technology, including applications in cancer and genetic diseases.
- How AI is accelerating drug discovery and development, potentially cutting timelines and costs.
- The increasing focus on ESG as companies invest in renewable energy and sustainable operations.
